Literature DB >> 11261677

Plasma prorenin levels may predict persistent microalbuminuria in children with diabetes.

F Chiarelli1, M Pomilio, F A De Luca, J Vecchiet, A Verrotti.   

Abstract

Diabetic microangiopathy is characterized by increased prorenin concentrations. In the present study, we evaluated plasma prorenin concentrations in a large group of adolescents with onset of diabetes during childhood to determine whether increasing prorenin levels may predict the development of persistent microalbuminuria. Ninety-seven young diabetic patients were studied; they were divided according to the presence of persistent microalbuminuria, at the end of follow-up, into group A and group B (patients who did not develop and who developed persistent microalbuminuria, respectively). One hundred and two healthy subjects, matched for age and sex, were also selected. Patients were followed up for at least 10 years. At the beginning of the study there were no significant differences in prorenin levels between either the two diabetic groups or the healthy controls. During follow-up, an increase in plasma prorenin started at 4 years and became statistically significant (P<0.01) 3 years before the onset of persistent microalbuminuria. No correlation was found between plasma prorenin levels and HbAlc percentages. In conclusion, an increased concentration of prorenin in plasma precedes the elevation of albumin excretion rate (AER) and, therefore, can be useful for identifying patients with onset of diabetes during childhood at risk of developing incipient nephropathy later in life.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11261677     DOI: 10.1007/s004670000514

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  11 in total

1.  Serum prorenin levels and diabetic retinopathy in type 2 diabetes: new method to measure serum level of prorenin using antibody activating direct kinetic assay.

Authors:  H Yokota; F Mori; K Kai; T Nagaoka; N Izumi; A Takahashi; T Hikichi; A Yoshida; F Suzuki; Y Ishida
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

Review 2.  The (pro)renin receptor and its interaction partners.

Authors:  Jörg Peters
Journal:  Pflugers Arch       Date:  2017-06-15       Impact factor: 3.657

3.  (Pro)renin receptor activation increases profibrotic markers and fibroblast-like phenotype through MAPK-dependent ROS formation in mouse renal collecting duct cells.

Authors:  Alexis A Gonzalez; Leonardo Zamora; Cristian Reyes-Martinez; Nicolas Salinas-Parra; Nicole Roldan; Catherina A Cuevas; Stefanny Figueroa; Alex Gonzalez-Vergara; Minolfa C Prieto
Journal:  Clin Exp Pharmacol Physiol       Date:  2017-08-30       Impact factor: 2.557

4.  Plasma and serum prorenin concentrations in diabetes, hypertension, and renal disease.

Authors:  Sayuki Kawamura; Kazumi Fujimoto; Akinori Hayashi; Yuji Kamata; Ibuki Moriguchi; Naoyuki Kobayashi; Masayoshi Shichiri
Journal:  Hypertens Res       Date:  2022-06-10       Impact factor: 5.528

5.  Oral renin inhibitors in clinical practice: a perspective review.

Authors:  Luca Bonanni; Michele Dalla Vestra
Journal:  Ther Adv Chronic Dis       Date:  2012-07       Impact factor: 5.091

6.  Role of aliskiren in blood pressure control and renoprotection.

Authors:  Hernán Trimarchi
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-03-22

7.  Prorenin independently causes hypertension and renal and cardiac fibrosis in cyp1a1-prorenin transgenic rats.

Authors:  Guangyu Zhou; Jie Wu; Chunyan Gu; Bin Wang; E Dale Abel; Alfred K Cheung; Yufeng Huang
Journal:  Clin Sci (Lond)       Date:  2018-06-28       Impact factor: 6.876

8.  α-Ketoglutarate Upregulates Collecting Duct (Pro)renin Receptor Expression, Tubular Angiotensin II Formation, and Na+ Reabsorption During High Glucose Conditions.

Authors:  Aarón Guerrero; Bruna Visniauskas; Pilar Cárdenas; Stefanny M Figueroa; Jorge Vivanco; Nicolas Salinas-Parra; Patricio Araos; Quynh My Nguyen; Modar Kassan; Cristián A Amador; Minolfa C Prieto; Alexis A Gonzalez
Journal:  Front Cardiovasc Med       Date:  2021-06-04

9.  IGF-1 and IGF-binding proteins and bone mass, geometry, and strength: relation to metabolic control in adolescent girls with type 1 diabetes.

Authors:  Laurie J Moyer-Mileur; Hillarie Slater; Kristine C Jordan; Mary A Murray
Journal:  J Bone Miner Res       Date:  2008-12       Impact factor: 6.741

Review 10.  Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy.

Authors:  Kalathil K Sureshkumar
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.